ArticleTargeted oncology2021

Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line.

Ondřej Fiala et al.PubMed ↗Publisher ↗

No numbers read from the abstract.